Skip to main content

Intra-Cellular Therapies, Inc.

ITCIDelisted Apr 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001567514

Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.

Members of Congress who traded ITCI

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
7
Filings
7
Members
2
Buys / sells
1 / 6
Estimated volume
$56.0K
Sum of range midpoints
Members of Congress who traded ITCI
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Gilbert Ray Cisneros, Jr.Democrat · House · CA20 / 2$16.0KApr 3, 2025May 6, 2025
Josh GottheimerDemocrat · House · NJ51 / 4$40.0KApr 3, 2025May 14, 2025

Trades

Every reported trade in Intra-Cellular Therapies, Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Josh GottheimerDemocrat · House · NJITCIIntra-Cellular Therapies Inc.SellJointApr 3, 2025May 14, 202541 days$1K-$15KFiling
Gilbert Ray Cisneros, Jr.Democrat · House · CAITCIIntra-Cellular Therapies Inc.SellSelfApr 3, 2025May 6, 202533 days$1K-$15KFiling
Josh GottheimerDemocrat · House · NJITCIIntra-Cellular Therapies Inc.Sell (partial)JointMar 17, 2025Apr 10, 202524 days$1K-$15KFiling
Gilbert Ray Cisneros, Jr.Democrat · House · CAITCIIntra-Cellular Therapies Inc.Sell (partial)SelfMar 24, 2025Apr 7, 202514 days$1K-$15KFiling
Josh GottheimerDemocrat · House · NJITCIIntra-Cellular Therapies Inc.Sell (partial)JointJan 24, 2025Feb 10, 202517 days$1K-$15KFiling
Josh GottheimerDemocrat · House · NJITCIIntra-Cellular Therapies Inc.Sell (partial)JointJun 21, 2024Jul 9, 202418 days$1K-$15KFiling
Josh GottheimerDemocrat · House · NJITCIIntra-Cellular Therapies Inc.BuyJointDec 21, 2021Jan 10, 202220 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.